SEC Form 4 · accession 0001179110-15-015239
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alla Danilkovitch
Officer — Chief Scientific Officer
Period of report
Nov 18, 2015
Accepted (ET)
Nov 20, 2015 · 5:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 19, 2015 | M | 4,000 | $5.08 | A | 11,950 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $5.08 | Nov 19, 2015 | M | 4,000 | D | Mar 23, 2013 | Mar 23, 2022 | Common Stock | 4,000 | 89,000 | D |